+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Nasopharynx Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Nasopharynx Cancer Market - Global Strategic Business Report

  • Report
  • February 2026
  • 287 Pages
  • Global
From
Oncolytic Virotherapy Market - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virotherapy Market - Global Strategic Business Report

  • Report
  • February 2026
  • 243 Pages
  • Global
From
Metastatic Cancer Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs Market - Global Strategic Business Report

  • Report
  • February 2026
  • 377 Pages
  • Global
From
From
From
From
Angiosarcoma Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment Market - Global Strategic Business Report

  • Report
  • February 2026
  • 390 Pages
  • Global
From
Pituitary Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Pituitary Cancer Market - Global Strategic Business Report

  • Report
  • February 2026
  • 575 Pages
  • Global
From
From
Gallbladder Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Gallbladder Cancer Market - Global Strategic Business Report

  • Report
  • February 2026
  • 395 Pages
  • Global
From
From
Oncolytic Virus Therapy Market - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virus Therapy Market - Global Strategic Business Report

  • Report
  • February 2026
  • 483 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 380 Pages
  • Global
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • February 2026
  • 211 Pages
  • Global
From
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • February 2026
  • 224 Pages
  • Global
From
Immune Checkpoint Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Immune Checkpoint Inhibitors - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
Urothelial Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Urothelial Cancer Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 126 Pages
  • Global
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • February 2026
  • 291 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 193 Pages
  • Global
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more